Bone Biologics BBLG
NASDAQ BBLG
$0.48 -0.02 (-3.12%)
As of: Sep 30, 2026 · 11:33 AM EDT

Bone Biologics Corp (BBLG) Operating Income (2014 - 2026)

Updated

Bone Biologics (BBLG) posted Operating Income of -$808,106 for Q2 2026, compared with -$748,075 a year earlier.

Analysis

Bone Biologics Corp (BBLG) Operating Income (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Income at Bone Biologics was -$3 million; for FY2025, it came in at -$3.23 million.

  • In prior years, Bone Biologics' Operating Income was -$4.22 million in FY2024, -$9.43 million in FY2023, -$3.67 million in FY2022 and -$1.1 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Operating Income since Q1 2025.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -808,106.00
Dec 31, 2025 -733,105.00
Sep 30, 2025 -715,274.00
Jun 30, 2025 -748,075.00
Mar 31, 2025 -1.04 Mn
Dec 31, 2024 -1.55 Mn
Sep 30, 2024 -951,021.00
Jun 30, 2024 -809,665.00
Mar 31, 2024 -903,536.00
Dec 31, 2023 -1.16 Mn
Sep 30, 2023 -2.08 Mn
Jun 30, 2023 -3.04 Mn
Mar 31, 2023 -3.15 Mn
Dec 31, 2022 -1.29 Mn
Sep 30, 2022 -1.22 Mn
Jun 30, 2022 -469,304.00
Mar 31, 2022 -689,499.00
Dec 31, 2021 -460,482.00
Sep 30, 2021 -229,789.00
Jun 30, 2021 -231,881.00
API Access

Bone Biologics Corp Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=BBLG&period=max&api_key=YOUR_API_KEY